Literature DB >> 9652428

Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.

E J Abrams1, J Weedon, R W Steketee, G Lambert, M Bamji, T Brown, M L Kalish, E E Schoenbaum, P A Thomas, D M Thea.   

Abstract

The utility of RNA virus load to predict progression of human immunodeficiency virus (HIV)-1 disease was assessed in 89 HIV-1-infected children. Of 22 virus load values during week 1 of life, 17 were below the detection threshold. Geometric mean virus load increased to approximately 7 x 10(5) copies/mL by week 4, was sustained throughout the first 6 months of life, and then declined to 1.6 x 10(5) copies/mL during the third year. Samples from week 1 of life had little predictive value, but virus load during days 7-30 strongly predicted progression to CDC-3 classification or death (P = .024; risk ratio = 1.6), and virus load during months 2-3 predicted progression to CDC-C or death within the first 6 months of life (P = .002, risk ratio = 11). Virus load was highly associated with imminent vulnerability to CDC-C or death (P = .002) during the first 18 months of life. Except for values from the first week of life, virus load at any age through 18 months is strongly associated with risk of HIV disease progression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9652428     DOI: 10.1086/515596

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  34 in total

1.  Viral load, CD4+ T-lymphocyte counts and antibody titres in HIV-1 infected untreated children in Kenya; implication for immunodeficiency and AIDS progression.

Authors:  Washingtone Ochieng; Dorington Ogoyi; Francis J Mulaa; Simon Ogola; Rachel Musoke; Moses G Otsyula
Journal:  Afr Health Sci       Date:  2006-03       Impact factor: 0.927

2.  12-month outcomes of HIV-infected infants identified at birth at one maternity site in Johannesburg, South Africa: an observational cohort study.

Authors:  Karl-Günter Technau; Renate Strehlau; Faeezah Patel; Stephanie Shiau; Megan Burke; Martie Conradie; Gillian Sorour; Gayle G Sherman; Ashraf Coovadia; Pamela M Murnane; Elaine J Abrams; Louise Kuhn
Journal:  Lancet HIV       Date:  2018-11-08       Impact factor: 12.767

3.  Acute cytomegalovirus infection is associated with increased frequencies of activated and apoptosis-vulnerable T cells in HIV-1-infected infants.

Authors:  Jennifer A Slyker; Sarah L Rowland-Jones; Tao Dong; Marie Reilly; Barbra Richardson; Vincent C Emery; Ann Atzberger; Dorothy Mbori-Ngacha; Barbara L Lohman-Payne; Grace C John-Stewart
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

4.  Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses.

Authors:  K Luzuriaga; M McManus; M Catalina; S Mayack; M Sharkey; M Stevenson; J L Sullivan
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 5.  The role of protease inhibitor therapy in children with HIV infection.

Authors:  Patrick J Gavin; Ram Yogev
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

6.  Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected african children.

Authors:  Elizabeth M Obimbo; Dorothy A Mbori-Ngacha; James O Ochieng; Barbra A Richardson; Phelgona A Otieno; Rose Bosire; Carey Farquhar; Julie Overbaugh; Grace C John-Stewart
Journal:  Pediatr Infect Dis J       Date:  2004-06       Impact factor: 2.129

7.  Genotype-guided antiretroviral regimens in children with multidrug-resistant HIV-1 infection.

Authors:  Gloria Huerta-García; José G Vazquez-Rosales; José A Mata-Marín; Leoncio Peregrino-Bejarano; Eric Flores-Ruiz; Fortino Solórzano-Santos
Journal:  Pediatr Res       Date:  2016-03-21       Impact factor: 3.756

8.  Comparison of human immunodeficiency virus type 1 viral loads in Kenyan women, men, and infants during primary and early infection.

Authors:  Barbra A Richardson; Dorothy Mbori-Ngacha; Ludo Lavreys; Grace C John-Stewart; Ruth Nduati; Dana D Panteleeff; Sandra Emery; Joan K Kreiss; Julie Overbaugh
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

9.  Mortality Rate and Predictors in Children Under 15 Years Old Who Acquired HIV from Mother to Child Transmission in Paraguay.

Authors:  Gloria Aguilar; Angélica Espinosa Miranda; George W Rutherford; Sergio Munoz; Nancy Hills; Tania Samudio; Fernando Galeano; Anibal Kawabata; Carlos Miguel Rios González
Journal:  AIDS Behav       Date:  2018-07

10.  Worldwide Genetic Features of HIV-1 Env α4β7 Binding Motif: The Local Dissemination Impact of the LDI Tripeptide.

Authors:  Sabrina H Hait; Esmeralda A Soares; Eduardo Sprinz; James Arthos; Elizabeth S Machado; Marcelo A Soares
Journal:  J Acquir Immune Defic Syndr       Date:  2015-12-15       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.